Brain metastases during follow-up of children and adolescents with extracranial malignant germ cell tumors: Risk adapted management decision tree analysis based on data of the MAHO/MAKEI-registry

Pediatric Blood and Cancer

Volumn 60, Issue 2, 2013, Pages 217-223

  Göbel, Ulrich ^a   Von Kries, Rüdiger ^a,b   Teske, Carmen ^c   Schneider, Dominik T ^d   Beyerlein, Andreas ^b   Bernbeck, Benedikt ^d   Calaminus, Gabriele ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d KLINIKUM DORTMUND   (Germany)

Author keywords

Adolescents; Children; Decision tree analysis; High risk group; Malignant germ cell tumor; Secondary brain metastases; Surveillance strategy

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; MESNA; VINBLASTINE;

ADOLESCENT; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CHILD; COHORT ANALYSIS; CONTINUOUS INFUSION; DECISION TREE; EXTRACRANIAL MALIGNANT GERM CELL TUMOR; FATALITY; FEMALE; FOLLOW UP; GERM CELL TUMOR; GERMANY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT TERATOMA; PATIENT MONITORING; PRIMARY TUMOR; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; DECISION TREES; FEMALE; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; REGISTRIES; RISK MANAGEMENT;

EID: 84871125237     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24229     Document Type: Article

References (26)

1. Nayak L, Hedvat C, Rosenblum MK, et al. Late relapse in primary central nervous system lymphoma: Clonal persistence. Neuro Oncol 2011; 13: 525-529.
2. Debling D, Spix C, Blettner M, et al. The cohort of long-term survivors at the german childhood cancer registry. Klin Padiatr 2008; 220: 371-377.
3. Calaminus G, Schneider DT, Bokkerink JP, et al. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: A prospective evaluation of 71 patients treated in the german cooperative protocols maligne keimzelltumoren (makei) 83/86 and makei 89. J Clin Oncol 2003; 21: 781-786.
4. Bussey KJ, Lawce HJ, Olson SB, et al. Chromosome abnormalities of eighty-one pediatric germ cell tumors: Sex-, age-, site-, and histopathology-related differences-A children's cancer group study. Genes Chromosomes Cancer 1999; 25: 134-146.
5. Perlman EJ, Cushing B, Hawkins E, et al. Cytogenetic analysis of childhood endodermal sinus tumors: A pediatric oncology group study. Pediatr Pathol 1994; 14: 695-708.
6. Schneider DT, Schuster AE, Fritsch MK, et al. Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents. Genes Chromosomes Cancer 2002; 34: 115-125.
7. Zahn S, Sievers S, Alemazkour K, et al. Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: A combined comparative genomic hybridization and microsatellite analysis. Genes Chromosomes Cancer 2006; 45: 995-1006.
8. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005; 5: 210-222.
9. Spunt SL, Walsh MF, Krasin MJ, et al. Brain metastases of malignant germ cell tumors in children and adolescents. Cancer 2004; 101: 620-626.
10. Gobel U, Schneider DT, Teske C, et al. Brain metastases in children and adolescents with extracranial germ cell tumor-Data of the maho/makei-registry. Klin Padiatr 2010; 222: 140-144.
11. Gobel U, Schneider DT, Calaminus G, et al. Germ-cell tumors in childhood and adolescence. Gpoh makei and the maho study groups. Ann Oncol 2000; 11: 263-271.
12. Oechsle K, Bokemeyer C. Treatment of brain metastases from germ cell tumors. Hematol Oncol Clin North Am 2011; 25: 605-613, ix.
13. McDonald JM, Doran S, DeSimone CP, et al. Predicting risk of malignancy in adnexal masses. Obstet Gynecol 2010; 115: 687-694.
14. Spurgeon SE, Hsieh YC, Rivadinera A, et al. Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsy. J Urol 2006; 175: 918-922.
15. Haas RJ, Bramswig J, Gobel U, et al. Malignant testicular tumors in children and adolescents: Concept of the maho 82 cooperative therapeutic study of the society for pediatric oncology. Klin Padiatr 1983; 195: 196-200.
16. Gobel U, Haas RJ, Harms D, et al. Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents-Concept of the makei 83 cooperative therapeutic study of the society for pediatric oncology. Klin Padiatr 1983; 195: 201-206.
17. Schmoll HJ, Kollmannsberger C, Metzner B, et al. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: An extended phase i/ii study of the german testicular cancer study group. J Clin Oncol 2003; 21: 4083-4091.
18. Atkinson E, Therneau T. An introduction to recursive partitioning using rpart routines. Technical Report, Mayo Clinic, Section of Statistics. 1997; 61.
19. Oechsle K, Kollmannsberger C, Honecker F, et al. Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy. Eur J Cancer 2008; 44: 1663-1669.
20. Einhorn LH, Williams SD, Chamness A, et al. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 2007; 357: 340-348.
21. Kollmannsberger C, Nichols C, Bamberg M, et al. First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases. Ann Oncol 2000; 11: 553-559.
22. Salvati M, Piccirilli M, Raco A, et al. Brain metastasis from non-seminomatous germ cell tumors of the testis: Indications for aggressive treatment. Neurosurg Rev 2006; 29: 130-137.
23. Cushing B, Giller R, Cullen JW, et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: A pediatric intergroup study-Pediatric oncology group 9049 and children's cancer group 8882. J Clin Oncol 2004; 22: 2691-2700.
24. Einhorn LH, Donohue JP. Improved chemotherapy in disseminated testicular cancer. J Urol 1977; 117: 65-69.
25. Marwaha S, Venner PM, North SA. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse. Can J Urol 2007; 14: 3692-3696.
26. Nichols C, Kollmannsberger C. First-line chemotherapy of disseminated germ cell tumors. Hematol Oncol Clin North Am 2011; 25: 543-556, viii.